BRUSSELS/LONDON, Oct 10 (Reuters) - Belgium’s Ablynx, which is using llamas to develop a new class of drugs, plans to raise funds through an initial public offering on Euronext Brussels this year, it said on Wednesday.
BRUSSELS/LONDON, Oct 10 (Reuters) - Belgium’s Ablynx, which is using llamas to develop a new class of drugs, plans to raise funds through an initial public offering on Euronext Brussels this year, it said on Wednesday.
